Skip to content

DMT: all studies

Page 71 of 160: studies 701 to 710 of 1,593, newest first. Back to the DMT overview

Research

Psychedelics: Historical Context, Emerging Science, and Future Clinical Frontiers

Journal of Mental Health Disorders April 18, 2026 Vipul Janardan, Amit Khanna, Om Prakash et al.

Psychedelics a class of psychoactive compounds such as psilocybin, lysergic acid diethylamide (LSD), and dimethyltryptamine (DMT) are undergoing a scientific renaissance. Studies since 2020 have shown their therapeutic promise in mental health treatment. This Commentary synthesizes historical usage, current neuroscientific and clinical evidence, and explores ethical and regulatory frontiers for...

Blinding Integrity in Psychedelic Randomized Clinical Trials

JAMA Psychiatry April 15, 2026 Diana Orsini, Sabrina Wong, Sara Di Luch et al. 4 citations

Importance: Psychedelic drugs possess acute psychoactive effects that can compromise blinding integrity in randomized clinical trials (RCTs). Functional unblinding, when participants or raters correctly identify treatment allocation based on subjective effects, may bias outcomes through expectancy effects, challenging the validity of efficacy estimates and regulatory acceptance. Objective: To...

DOI: 10.1001/jamapsychiatry.2026.0255 (opens in new tab) Blinding Randomized controlled trial Clinical trial Meta-analysis +4

Hallucinogenic Therapy in Alzheimer's Disease targeting Mitochondria-Associated Membranes.

Neuroscience April 6, 2026 Fernando Minauro-Sanmiguel, Hector Vargas-Perez

Mitochondrial dysfunction is increasingly recognized as a central driver of Alzheimer's disease (AD), contributing to neuroinflammation, synaptic failure, and energy collapse.Emerging preclinical evidence suggests that classic hallucinogens, such as psilocybin, lysergic acid diethylamide (LSD), N,N-dimethyltryptamine (DMT), mescaline, may restore mitochondrial integrity by activating Serotonin...

COMPUTAÇÃO SIMBIÓTICA BIOMIMÉTICA E A ARQUITETURA HOLOGRÁFICA DA CONSTRUÇÃO DA REALIDADE 2.0: FUNDAMENTOS TEÓRICOS, FORMALIZAÇÃO MATEMÁTICA E VALIDAÇÃO EXPERIMENTAL

Revista Tópicos April 5, 2026 Muriel Fernandes

O presente artigo propõe a formalização da Computação Simbiótica Biomimética (CSB) como campo científico emergente, fundamentado na Arquitetura Holográfica da Construção da Realidade 2.0 (AHCR 2.0). A CSB é definida como o conjunto de princípios, métodos e tecnologias que imitam o funcionamento funcional do cérebro humano para criar interfaces bidirecionais entre domínios biológicos e...

Responsible Ceremonial Medicine: A Review of Current Evidence, Safety Protocols, and Ethical Considerations for Professional Practice

Zenodo (CERN European Organization for Nuclear Research) April 3, 2026 Espinoza Patricio preprint

This article reviews the current clinical evidence for psilocybin and ayahuasca as therapeutic agents, examining data from over 134 registered clinical trials and key publications in the New England Journal of Medicine, JAMA, JAMA Psychiatry, and Nature Neuroscience. The review addresses four dimensions: (1) the state of clinical evidence for psilocybin and ayahuasca in major depression and...

DOI: 10.5281/zenodo.19392796 (opens in new tab) Psilocybin Ayahuasca Clinical trial Perspective graphical +8

POTENCIAL TERAPÊUTICO DA HOASCA NO TRATAMENTO DA DEPRESSÃO: REVISÃO DE ESCOPO

Revista Políticas Públicas & Cidades April 2, 2026 Adrian Santos de Souza, Endiamara Magda Segala Shigemori, Celso Ferraz Bett

A depressão é uma das principais causas de incapacidade no mundo, e suas abordagens terapêuticas convencionais, embora eficazes para muitos pacientes, ainda apresentam limitações significativas, como início tardio dos efeitos e resistência ao tratamento. Nesse contexto, destaca-se a hoasca, também conhecida como ayahuasca, uma infusão amazônica tradicional composta por Banisteriopsis caapi e...

DOI: 10.23900/2359-1552v15n4-4-2026 (opens in new tab) Context archaeology Scielo Gynecology

Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action.

Pharmacology Research & Perspectives April 1, 2026 Jordana Kazdan, Karim S Ladha, Muhammad Ishrat Husain

Major Depressive Disorder (MDD) and chronic pain are independently debilitating conditions that frequently co-occur. This comorbidity poses a significant clinical challenge, resulting in greater symptom severity, higher disability, and worse prognosis than either condition alone. Current therapies often address each disorder in isolation, leaving individuals with comorbid MDD and chronic pain...

Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants

Science Advances April 1, 2026 Paula Berman, Janka Höfer, Herschel Mehlman et al. 1 citation

-dimethyltryptamine (DMT) biosynthetic pathway in hallucinogenic plant species traditionally used in shamanic rituals for spiritual healing. Leveraging the similarities in their chemical structures, we reconstructed in one plant assay the full biosynthetic pathways of five renowned natural psychedelics; psilocin and psilocybin found in mushrooms, DMT from plants, and bufotenin and 5-methoxy-DMT...

An international mega-analysis of psychedelic drug effects on brain circuit function

Nature Medicine April 1, 2026 Manesh Girn, Manoj K. Doss, Leor Roseman et al. 8 citations

Psychedelic drugs are re-emerging as promising scientific and clinical tools. However, despite a rapidly expanding literature on their therapeutic value, the neural mechanisms underlying psychedelic effects remain unclear. Resting-state functional magnetic resonance imaging studies of acute psychedelic effects, conducted independently by several research groups, have so far yielded fragmented...

Falso positivo en el cribado de anfetaminas secundario a dimetiltriptamina

Adicciones March 31, 2026 Bernardino Barceló Martín, José Manuel Arteaga Armas, Isabel Gomila Muñiz et al.

Se recomienda la inclusión de la DMT en los protocolos de sumisión química en los que se sospeche la asistencia de las víctimas a rituales espirituales o cuando las pacientes refieren haber sufrido breves pero intensas alucinaciones visuales y auditivas. La posibilidad de que la DMT provoque resultados falsos positivos en los cribados de anfetaminas permite sospechar su presencia. No obstante,...

DOI: 10.20882/adicciones.2233 (opens in new tab) Poison control Medical screening Occupational medicine